The victory gives Pfizer a long-awaited foothold in the booming weight-loss drug market as Novo retreats amid U.S. antitrust fears.
BUSINESS
The victory gives Pfizer a long-awaited foothold in the booming weight-loss drug market as Novo retreats amid U.S. antitrust fears.
Market Insider empowers investors to stay ahead of the curve. We deliver the essential news, data, and expert analysis across stocks, commodities, crypto, gold, and policy, ensuring you have the global market intelligence needed for timely, informed decision-making.
@2025 – All Right Reserved. Operated by Insider LLC